‘Accelerating
Change Together for Cancer Care in Africa’ aims to tackle the growing burden of
cancer across continent and improve patient outcomes
AstraZeneca and health partners today launched an initiative to transform outcomes for cancer patients across Africa.
Announced on the margins of the UN Climate Change Conference 2022, COP27, under the patronage of the Egyptian Ministry of Health, the Accelerating Change Together; Cancer Care in Africa (ACT;CCA) programme provides a platform for partners to co-create cancer care solutions that close the gaps in existing patient care pathway, from diagnosis through to treatment and beyond.
At the inaugural event,
government representatives, leading clinical and health experts, patient
advocates, and private sector representatives signed the ACT;CCA Coalition
Declaration to reaffirm their joint commitment to advancing equitable
cancer outcomes for all Africans.
“While cancer treatment developments are moving quickly, equitable
access to these innovations is not there for all. Our ambition is to nurture
the cancer care ecosystem in Africa, bringing together local stakeholders to
co-create solutions and encourage long-term investment that leads to equitable
cancer outcomes. We need joint action to reverse the alarming increase in
Africa’s cancer burden, by addressing the unique barriers to cancer diagnosis
and treatment, as well as building capacity that helps to make innovative care
accessible to patients,” said Pelin Incesu, Area Vice President for the
Middle East and Africa, AstraZeneca.
Over 700,000 deaths occurred due to cancer
across the region in 2020; across Sub-Saharan Africa the current mortality
rates are reaching 70 per cent in diagnosed cases. An estimated 2.1 million new
cancer cases and 1.4 million deaths are expected annually by 2040 across the
continent.[1]
Cancers of the breast and prostate are the among the top three most prevalent.[2]
ACT;CCA focuses on driving
impact in lung, breast and prostate cancer through capacity building, early
screening and diagnosis and patient empowerment. It is the regional chapter of
the global Accelerating Change Together (ACT) for Cancer
Care, an AstraZeneca-led effort to revolutionize the way cancer is diagnosed
and treated to drive improvements in patient outcomes.
Over the next three years, ACT;CCA aims to drive screening and
diagnostics covering one million people across cancer types, and to provide
training for more than 10,000 healthcare professionals across 100 oncology
centres.
The programme is led by a steering committee of doctors, oncology
institutions and advocacy groups to guide policy intervention, share learnings
across borders, and put cancer patients at the centre. Members will meet on a
regular basis to drive progress on cancer initiatives.
Dr Mohsen
Mokhtar, Professor of Clinical Oncology and Managing Director of Cairo
University Cancer Center, President of Can-Survive-Egypt, said collaboration was key to improving cancer
outcomes. “Each country joining the coalition invests heavily in cancer care programmes.
We understand that by working together to develop a network that stretches
beyond borders, we can close the gaps across the patient care pathway and
provide solutions that improve outcomes and transform the patient journey not
only for our own citizens, but across the continent.”
Dr Mary Nyangasi, Head of National Cancer
Control Programme in Kenya, highlighted the disparity in care. “In some
areas, the lack of disease awareness, limited diagnostic capabilities, and an
absence of structured programmes for early detection and access to treatment
mean that equitable cancer care is not there for all. ACT;CCA is about
levelling the playing field and collaborating to transform patient outcomes.”
Launch events are planned over the coming months in Algeria, Morocco and
Kenya focused on local initiatives under the ACT;CCA umbrella.
– Ends –
Post a Comment